Peginterferon alfa-2a (40 kDa)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Peginterferon alfa-2a (40 kDa), covering 2010-06-11 to 2010-06-11. Get the full timeline:
Most recent: Clinical Trial Update: Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment [Phase 4]